WAM
IMVT icon

Wolverine Asset Management’s Immunovant IMVT Stock Holding History

Wolverine Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-176,157
Closed -$1.76M – 1444
2019
Q3 		$1.76M Buy
+176,157
New +$1.74M 0.02% 456

Other funds holding IMVT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Wolverine Asset Management's IMVT Position: Q4 2019 in Review

Wolverine Asset Management sold out of Immunovant (IMVT) in Q4 2019, closing a stake of 176,157 shares — an estimated $1.76M sold.

Wolverine Asset Management first reported a position in IMVT in Q3 2019 and held it in 1 quarter. The position peaked at $1.76M in Q3 2019. 24 funds tracked by Wall St. Rank hold IMVT as of Q4 2019.

  • Wolverine Asset Management reported no remaining Immunovant position as of Q4 2019 after selling out during the quarter.
  • Wolverine Asset Management sold 176,157 Immunovant shares in Q4 2019, an estimated $1.76M.
  • Wolverine Asset Management first reported a position in Immunovant in Q3 2019 and held it in 1 quarter.
  • Wolverine Asset Management's Immunovant position peaked at $1.76M in Q3 2019.
  • 24 funds tracked by Wall St. Rank held Immunovant as of Q4 2019.

Based on Wolverine Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.